newsfilter
← Latest News
Business Wire·

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim